Trump administration officials passed when Pfizer Inc offered in late summer to sell more vaccine doses to the US , the New York Times reported , citing people familiar with the matter . 
The drugmaker now may not be able to provide more of its vaccine to the US until next June because of its commitments to other countries , the newspaper reported . 
